speb/financial-data huggingface dataset:
Financial ratios for TRS.V — quarterly report dated 2025-02-28
Total revenue: 0
Operating income: -60931.944444444445
Net income: -72577.77777777778
Capital expenditures: 0
Operating cash flow: -8334.722222222223
Net tangible assets: 1514264.5833333335
Owner earnings: -72577.77777777778
Return on net tangible assets (%): -4.792939000000458
Buffett classification: The Gruesome
Stock price: 0.04861111111111112
Shares outstanding: 25233863
Book value: 1514264.5833333335
P/B ratio: 0.8100606271562883
Market cap (USD): 1226646.1180555557
Debt to equity: 0.03079786163158592
Current ratio: 0.3422483191086809
Quick ratio: 0.3422483191086809
Free cash flow (dilution-adjusted): -8334.722222222223
Buyback yield (%): 0
Retained earnings: -11805981.944444444
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.4600340474732345
Rule of 40 score: 0
Financial ratios for TRS.V — annual report dated 2025-02-28
Total revenue: 0
Operating income: -107452.08333333334
Net income: -115377.77777777778
Capital expenditures: 0
Operating cash flow: -50290.27777777778
Net tangible assets: 1514264.5833333335
Owner earnings: -115377.77777777778
Return on net tangible assets (%): -7.619393535824366
Buffett classification: The Gruesome
Stock price: 0.04861111111111112
Shares outstanding: 25233863
Book value: 1514264.5833333335
P/B ratio: 0.8100606271562883
Market cap (USD): 1226646.1180555557
Debt to equity: 0.03079786163158592
Current ratio: 0.3422483191086809
Quick ratio: 0.3422483191086809
Free cash flow (dilution-adjusted): -50290.27777777778
Buyback yield (%): 0
Retained earnings: -11805981.944444444
Receivables turnover: 0
Capitalized R&D asset: 1601.4705882352941
ROCI (R&D-adjusted, %): -6.18792166522658
Rule of 40 score: 0
Financial ratios for TRS.V — quarterly report dated 2025-05-31
Total revenue: 0
Operating income: -4881.159420289855
Net income: -11282.608695652174
Capital expenditures: 0
Operating cash flow: -17098.550724637684
Net tangible assets: 1549390.579710145
Owner earnings: -11282.608695652174
Return on net tangible assets (%): -0.7281965466553236
Buffett classification: The Gruesome
Stock price: 0.043478260869565216
Shares outstanding: 25233863
Book value: 1549390.579710145
P/B ratio: 0.7081006510741249
Market cap (USD): 1097124.4782608696
Debt to equity: 0.03866410309055594
Current ratio: 0.2584713878492418
Quick ratio: 0.2584713878492418
Interest coverage ratio: -0.6957240239619913
Free cash flow (dilution-adjusted): -17098.550724637684
Buyback yield (%): 0
Retained earnings: -12331727.536231885
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.2691946022006339
Rule of 40 score: 0
Financial ratios for TRS.V — quarterly report dated 2025-08-31
Total revenue: 0
Operating income: -19298.5401459854
Net income: 102411.67883211678
Capital expenditures: 0
Operating cash flow: -23662.043795620437
Net tangible assets: 1685018.2481751824
Owner earnings: 102411.67883211678
Return on net tangible assets (%): 6.077778620084688
Buffett classification: The Gruesome
Stock price: 0.0437956204379562
P/E ratio: 335.1201358608341
Shares outstanding: 25233863
Book value: 1685018.2481751824
P/B ratio: 0.6558579928307648
Market cap (USD): 1105132.6861313868
Debt to equity: 0.043495381149893333
Current ratio: 0.4639669309823592
Quick ratio: 0.4639669309823592
Free cash flow (dilution-adjusted): -23662.043795620437
Buyback yield (%): 0
Retained earnings: -12319328.467153283
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.9863487747771676
Rule of 40 score: 0
Financial ratios for TRS.V — quarterly report dated 2025-11-30
Total revenue: 0
Operating income: -8867.857142857143
Net income: -16936.428571428572
Capital expenditures: 0
Operating cash flow: -5859.285714285715
Net tangible assets: 1610672.8571428573
Owner earnings: -16936.428571428572
Return on net tangible assets (%): -1.0515126331408968
Buffett classification: The Gruesome
Stock price: 0.05000000000000001
P/E ratio: 781.3000452144175
Shares outstanding: 25233863
Book value: 1610672.8571428573
P/B ratio: 0.7833329682093819
Market cap (USD): 1261693.1500000001
Debt to equity: 0.0452965087350362
Current ratio: 0.2983179625602959
Quick ratio: 0.2983179625602959
Interest coverage ratio: -1.2963349691970345
Free cash flow (dilution-adjusted): -5859.285714285715
Buyback yield (%): 0
Retained earnings: -12075400.714285715
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.47040556044758813
Rule of 40 score: 0
Financial ratios for TTKHLTCARE.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.473691151259397
Shares outstanding: 14130333
Market cap (USD): 147996743.70644864
Buyback yield (%): 0
Retained earnings: 26499287.88078597
Capitalized R&D asset: 386918.1062903864
Rule of 40 score: 0
Financial ratios for TTKHLTCARE.NS — annual report dated 2023-03-31
Total revenue: 87720767.35688186
Gross profit: 45050499.39098661
Operating income: 2325334.957369062
Net income: 77918745.43239951
Capital expenditures: 1393276.4920828259
Operating cash flow: -3022070.6455542026
Depreciation & amortization: 1573434.8355663826
Net tangible assets: 116120280.14616323
Owner earnings: 78098903.77588308
Return on net tangible assets (%): 67.25690265092214
Capex to operating income (%): 59.91723848934053
Buffett classification: The Good
Stock price: 12.241047503045069
P/E ratio: 2.2198775984773795
Shares outstanding: 14130333
Book value: 116124738.12423873
P/B ratio: 1.4895196344967367
Market cap (USD): 172970077.48684534
Debt to equity: 0.028664942073189602
Current ratio: 5.057763572333036
Quick ratio: 4.656802190341678
Effective tax rate (%): 27.529057882133056
Interest coverage ratio: 3.644085590486552
COGS to revenue (%): 48.64329080968498
R&D to revenue (%): 0.18391043998958603
SG&A to revenue (%): 19.576762995747636
Free cash flow (dilution-adjusted): -4447052.375152254
Buyback yield (%): 0
Retained earnings: 100703288.6723508
Inventory turnover: 4.1451169383751445
Receivables turnover: 7.819701821190435
Capitalized R&D asset: 420562.7804228415
ROCI (R&D-adjusted, %): 1.9646296166485875
FCF margin (%): -5.069554803436605
Rule of 40 score: -5.069554803436605
Financial ratios for TTKHLTCARE.NS — annual report dated 2024-03-31
Total revenue: 89655762.08178438
Gross profit: 48818599.35244034
Operating income: 2996642.2832473917
Net income: 7535903.5855618175
Capital expenditures: 1230111.5241635689
Operating cash flow: -592792.9008274373
Depreciation & amortization: 1565979.1341887517
Net tangible assets: 120027952.99196546
Owner earnings: 7871771.195587
Return on net tangible assets (%): 6.55828163304087
Capex to operating income (%): 41.04966185121454
Buffett classification: The Good
Stock price: 17.280470249520153
P/E ratio: 32.402059852535764
Shares outstanding: 14130333
Book value: 120028648.51900706
P/B ratio: 2.0343376521784804
Market cap (USD): 244178799.02231285
Debt to equity: 0.022789658582728335
Current ratio: 5.345826127733269
Quick ratio: 4.86453852318487
Effective tax rate (%): 25.295202228237418
Interest coverage ratio: 12.957739175525019
COGS to revenue (%): 45.54884346651608
R&D to revenue (%): 0.15112900684474362
SG&A to revenue (%): 20.687473132100852
Free cash flow (dilution-adjusted): -1837954.191150018
Buyback yield (%): 0
Retained earnings: 104883775.03297758
Inventory turnover: 3.5111021983754993
Receivables turnover: 8.649209511315336
Capitalized R&D asset: 371268.36285866384
ROCI (R&D-adjusted, %): 2.402911360047202
Rosenberg metric: 23.356814408105073
FCF margin (%): -2.0500123455237915
Revenue growth (%): 2.205857042985297
Rule of 40 score: 0.15584469746150553
Financial ratios for TTKHLTCARE.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 124077030.57811753
Buffett classification: The Gruesome
Stock price: 19.641304347826086
Shares outstanding: 14130333
Book value: 124077090.30100334
P/B ratio: 2.236820434101412
Market cap (USD): 277538170.98913044
Debt to equity: 0.029994992170573487
Current ratio: 5.167357678663587
Quick ratio: 4.697727934711968
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TTKHLTCARE.NS — quarterly report dated 2024-12-31
Total revenue: 23865811.866184868
Gross profit: 12438990.558340132
Operating income: 650413.8011423242
Net income: 1950390.4884019115
Capital expenditures: 0
Depreciation & amortization: 246042.66231495512
Owner earnings: 2196433.1507168664
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.12041030423126
P/E ratio: 29.19758466957818
Shares outstanding: 14130333
Market cap (USD): 227786765.695419
Effective tax rate (%): 25.941531856507403
Interest coverage ratio: 6.777480869670836
COGS to revenue (%): 47.87945774447019
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TTKHLTCARE.NS — annual report dated 2025-03-31
Total revenue: 93246153.84615384
Gross profit: 49778875.379939206
Operating income: 3148620.5284077623
Net income: 9546048.632218845
Capital expenditures: 1222340.4255319147
Operating cash flow: -464776.712649053
Depreciation & amortization: 974245.9667991583
Net tangible assets: 124508791.2087912
Owner earnings: 9297954.17348609
Return on net tangible assets (%): 7.467708973171357
Capex to operating income (%): 38.82145893744918
Buffett classification: The Good
Stock price: 13.645349515696115
P/E ratio: 20.198234891388573
Shares outstanding: 14130333
Book value: 124508791.20879121
P/B ratio: 1.5485921169601784
Market cap (USD): 192813332.55817482
Debt to equity: 0.02274028536924432
Current ratio: 5.233622111565779
Quick ratio: 4.718796566141878
Effective tax rate (%): 24.623333130253535
Interest coverage ratio: 13.820453612479476
COGS to revenue (%): 46.61562613931614
R&D to revenue (%): 0.0205358992091046
SG&A to revenue (%): 18.604070370684266
Free cash flow (dilution-adjusted): -1965805.47112462
Buyback yield (%): 0
Retained earnings: 109906441.43090951
Inventory turnover: 3.424108055541742
Receivables turnover: 8.810789972218693
Capitalized R&D asset: 163169.2884938483
ROCI (R&D-adjusted, %): 2.4444481563813647
Rosenberg metric: 7.087124341369168
FCF margin (%): -2.108189335474349
Revenue growth (%): 4.004641398390309
Rule of 40 score: 1.8964520629159596
Financial ratios for TTKHLTCARE.NS — quarterly report dated 2025-03-31
Total revenue: 22253869.534720596
Gross profit: 12024152.443301378
Operating income: 1149859.7147533316
Net income: 1887806.8739770865
Capital expenditures: 0
Depreciation & amortization: 253320.084171148
Net tangible assets: 124508791.2087912
Owner earnings: 2141126.9581482345
Return on net tangible assets (%): 1.719659260491685
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 13.645349515696115
P/E ratio: 25.534038361663885
Shares outstanding: 14130333
Book value: 124508791.20879121
P/B ratio: 1.5485921169601784
Market cap (USD): 192813332.55817482
Debt to equity: 0.02274028536924432
Current ratio: 5.233622111565779
Quick ratio: 4.718796566141878
Effective tax rate (%): 25.77541827541828
Interest coverage ratio: 10.872001768542058
COGS to revenue (%): 45.968262173276266
Buyback yield (%): 0
Retained earnings: 109906441.43090951
Inventory turnover: 0.8058396553597706
Receivables turnover: 2.102758799715007
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9190165861942795
Revenue growth (%): -6.754190221989516
Rule of 40 score: -6.754190221989516
Financial ratios for TTKHLTCARE.NS — quarterly report dated 2025-06-30
Total revenue: 26495413.058740932
Gross profit: 14581230.985256262
Operating income: 57044.23121928388
Net income: 1521109.2908963258
Capital expenditures: 0
Depreciation & amortization: 256037.91247367192
Owner earnings: 1777147.2033699977
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 14.688626257898433
P/E ratio: 38.72799109373636
Shares outstanding: 14130333
Market cap (USD): 207555180.33664873
Effective tax rate (%): 26.36361061545869
Interest coverage ratio: 0.6334459459459459
COGS to revenue (%): 44.96696106254566
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 19.059802239797712
Rule of 40 score: 19.059802239797712
Financial ratios for TTKHLTCARE.NS — quarterly report dated 2025-12-31
Total revenue: 23315016.15238944
Gross profit: 12441093.906650329
Operating income: 547577.1415840482
Net income: 1173287.289740448
Capital expenditures: 0
Depreciation & amortization: 247465.74579480896
Owner earnings: 1420753.0355352568
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.454717611674278
P/E ratio: 24.777136874850672
Shares outstanding: 14130333
Market cap (USD): 161858974.27392223
Effective tax rate (%): 25.23230473269871
Interest coverage ratio: 7.194964871194379
COGS to revenue (%): 46.63913666053668
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -12.003575484180901
Rule of 40 score: -12.003575484180901
Financial ratios for VFF — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.42
Shares outstanding: 121811130
Market cap (USD): 782027454.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VFF — annual report dated 2022-12-31
Total revenue: 293572000
Gross profit: 27497000
Operating income: -44768000
Net income: -101146000
Capital expenditures: 14292000
Operating cash flow: -19889000
Depreciation & amortization: 13054000
Net tangible assets: 199681000
Owner earnings: -102384000
Return on net tangible assets (%): -51.27378168178244
Buffett classification: The Gruesome
Stock price: 1.34
Shares outstanding: 121811130
Book value: 319994000
P/B ratio: 0.5100936711313337
Market cap (USD): 163226914.20000002
Debt to equity: 0.2211010206441371
Current ratio: 1.8415010731842416
Quick ratio: 0.8641141037180641
Interest coverage ratio: -13.800246609124537
COGS to revenue (%): 90.63364353548704
SG&A to revenue (%): 24.615767171256113
Free cash flow (dilution-adjusted): -38168000
Buyback yield (%): 0
Retained earnings: -74367000
Inventory turnover: 3.769728826046301
Receivables turnover: 8.44398423792677
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.389319968453455
FCF margin (%): -13.001239900262968
Rule of 40 score: -13.001239900262968
Financial ratios for VFF — annual report dated 2023-12-31
Total revenue: 163109000
Gross profit: 47952000
Operating income: -8762000
Net income: -34798000
Capital expenditures: 3604000
Operating cash flow: 5315000
Depreciation & amortization: 14090000
Net tangible assets: 211432000
Owner earnings: -24312000
Return on net tangible assets (%): -11.49873245298725
Buffett classification: The Gruesome
Stock price: 0.76
Shares outstanding: 121811130
Book value: 315941000
P/B ratio: 0.29301818630693705
Market cap (USD): 92576458.8
Debt to equity: 0.2073330147084424
Current ratio: 2.1033316702699705
Quick ratio: 1.0157991019457842
Interest coverage ratio: -1.9492769744160179
COGS to revenue (%): 70.60125437590814
SG&A to revenue (%): 40.15780858199118
Free cash flow (dilution-adjusted): -1400000
Buyback yield (%): 0
Retained earnings: -109165000
Inventory turnover: 1.4674915893567133
Receivables turnover: 5.286306919462
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.2361567300355
FCF margin (%): -0.8583217357717845
Revenue growth (%): -44.439864837246056
Rule of 40 score: -45.29818657301784
Financial ratios for VFF — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.93
Shares outstanding: 121811130
Market cap (USD): 113284350.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VFF — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.77
Shares outstanding: 121811130
Market cap (USD): 93794570.10000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VFF — annual report dated 2024-12-31
Total revenue: 195907000
Gross profit: 45801000
Operating income: -15947000
Net income: -35644000
Capital expenditures: 7168000
Operating cash flow: 10347000
Depreciation & amortization: 16723000
Net tangible assets: 186585000
Owner earnings: -26089000
Return on net tangible assets (%): -13.982367285687488
Buffett classification: The Gruesome
Stock price: 0.77
Shares outstanding: 121811130
Book value: 263958000
P/B ratio: 0.35533899370354377
Market cap (USD): 93794570.10000001
Debt to equity: 0.18874593685359034
Current ratio: 1.8646876356097013
Quick ratio: 1.201610440540671
Interest coverage ratio: -4.739078751857355
COGS to revenue (%): 76.621049783826
SG&A to revenue (%): 31.5190370941314
Free cash flow (dilution-adjusted): -726000
Buyback yield (%): 0
Retained earnings: -145016000
Inventory turnover: 3.6384041109172
Receivables turnover: 8.743115990538671
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.87546126871444
FCF margin (%): -0.3705840015925924
Revenue growth (%): 20.10802592131642
Rule of 40 score: 19.737441919723825
Financial ratios for VFF — quarterly report dated 2025-03-31
Total revenue: 39680000
Gross profit: 14179000
Operating income: -440000
Net income: -6703000
Capital expenditures: 1249000
Operating cash flow: -6377000
Depreciation & amortization: 4439000
Net tangible assets: 181495000
Owner earnings: -3513000
Return on net tangible assets (%): -1.9355905121353205
Buffett classification: The Gruesome
Stock price: 0.61
Shares outstanding: 121811130
Book value: 257953000
P/B ratio: 0.2880555345353611
Market cap (USD): 74304789.3
Debt to equity: 0.21200373711490078
Current ratio: 1.9221421894759994
Quick ratio: 0.978995986143949
Interest coverage ratio: -0.6276747503566333
COGS to revenue (%): 64.26663306451613
SG&A to revenue (%): 42.28578629032258
Free cash flow (dilution-adjusted): -7771000
Buyback yield (%): 0
Retained earnings: -151719000
Inventory turnover: 0.4955595716978565
Receivables turnover: 1.133973479652492
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.1364159197378334
FCF margin (%): -19.584173387096772
Rule of 40 score: -19.584173387096772
Financial ratios for VFF — quarterly report dated 2025-06-30
Total revenue: 59899000
Gross profit: 22342000
Operating income: 6931000
Net income: 26497000
Capital expenditures: 4040000
Operating cash flow: 21824000
Depreciation & amortization: 3971000
Net tangible assets: 214813000
Owner earnings: 26428000
Return on net tangible assets (%): 12.302793592566557
Capex to operating income (%): 58.28884720819506
Buffett classification: The Good
Stock price: 1.1
P/E ratio: 6.769336314034557
Shares outstanding: 121811130
Book value: 294192000
P/B ratio: 0.45545848629466473
Market cap (USD): 133992243.00000001
Debt to equity: 0.14910330668407026
Current ratio: 2.654824392126592
Quick ratio: 1.8930335777692011
Effective tax rate (%): 20.107647814910028
Interest coverage ratio: 8.514742014742014
COGS to revenue (%): 62.70054591896359
SG&A to revenue (%): 25.728309320689828
Free cash flow (dilution-adjusted): 17661000
Buyback yield (%): 0
Retained earnings: -125222000
Inventory turnover: 0.9513881852264667
Receivables turnover: 2.1353605932052333
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9694593150793922
FCF margin (%): 29.484632464648826
Revenue growth (%): 50.955141129032256
Rule of 40 score: 80.43977359368108
Financial ratios for VFF — quarterly report dated 2025-09-30
Total revenue: 66741000
Gross profit: 31938000
Operating income: 16339000
Net income: 10540000
Capital expenditures: 1828000
Operating cash flow: 25398000
Depreciation & amortization: 4162000
Net tangible assets: 227917000
Owner earnings: 12874000
Return on net tangible assets (%): 5.648547497553935
Capex to operating income (%): 11.187955199216598
Buffett classification: The Great
Stock price: 3.13
P/E ratio: 12.56902607305334
Shares outstanding: 121811130
Book value: 305365000
P/B ratio: 1.2485675729045569
Market cap (USD): 381268836.9
Debt to equity: 0.12832839388928005
Current ratio: 2.7767436088359396
Quick ratio: 2.170371946246853
Effective tax rate (%): 30.367604455031223
Interest coverage ratio: 25.292569659442723
COGS to revenue (%): 52.14635681215445
SG&A to revenue (%): 23.372439729701384
Free cash flow (dilution-adjusted): 22556000
Buyback yield (%): 0
Retained earnings: -115005000
Inventory turnover: 1.0175423208490484
Receivables turnover: 2.0902286251174442
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.513810231561035
FCF margin (%): 33.79631710642633
Revenue growth (%): 11.422561311541095
Rule of 40 score: 45.218878417967424
Financial ratios for VFF — annual report dated 2025-12-31
Total revenue: 215937000
Gross profit: 87682000
Operating income: 27389000
Net income: 32441000
Capital expenditures: 18219000
Operating cash flow: 49724000
Depreciation & amortization: 16379000
Net tangible assets: 231886000
Owner earnings: 30601000
Return on net tangible assets (%): 13.196570728720147
Capex to operating income (%): 66.51940560078864
Buffett classification: The Good
Stock price: 3.65
P/E ratio: 13.705207129866526
Shares outstanding: 121811130
Book value: 310062000
P/B ratio: 1.4339410327611897
Market cap (USD): 444610624.5
Debt to equity: 0.12483632305796905
Current ratio: 2.636073464650258
Quick ratio: 1.9273887959580787
Effective tax rate (%): 33.071845403233525
Interest coverage ratio: 10.129068047337277
COGS to revenue (%): 59.39463825097134
SG&A to revenue (%): 27.921569717093416
Free cash flow (dilution-adjusted): 29369000
Buyback yield (%): 0.6682251471928107
Retained earnings: -112575000
Inventory turnover: 3.089067655772056
Receivables turnover: 9.198594249201278
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.513922800471866
FCF margin (%): 13.600726137716093
Revenue growth (%): 10.224239052203341
Rule of 40 score: 23.824965189919432
Financial ratios for VFF — quarterly report dated 2025-12-31
Total revenue: 49617000
Gross profit: 19222000
Operating income: 4558000
Net income: 2441000
Capital expenditures: 11102000
Operating cash flow: 8879000
Depreciation & amortization: 3807000
Net tangible assets: 231886000
Owner earnings: -4854000
Return on net tangible assets (%): -2.093269968864011
Capex to operating income (%): 243.57174199210178
Buffett classification: The Gruesome
Stock price: 3.65
P/E ratio: 13.565541556064073
Shares outstanding: 121811130
Book value: 310062000
P/B ratio: 1.4339410327611897
Market cap (USD): 444610624.5
Debt to equity: 0.12483632305796905
Current ratio: 2.636073464650258
Quick ratio: 1.9273887959580787
Effective tax rate (%): 48.1029509651653
Interest coverage ratio: 8.409594095940959
COGS to revenue (%): 61.259245823004214
SG&A to revenue (%): 29.554386601366467
Free cash flow (dilution-adjusted): -3077000
Buyback yield (%): 0
Retained earnings: -112575000
Inventory turnover: 0.7320744719285146
Receivables turnover: 2.1136102236421723
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2504458039559958
FCF margin (%): -6.201503516939758
Revenue growth (%): -25.657392007911177
Rule of 40 score: -31.858895524850936
Financial ratios for VLYPO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.5
Shares outstanding: 331492000
Market cap (USD): 5801110000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VLYPO — annual report dated 2022-12-31
Total revenue: 1861952000
Net income: 568851000
Capital expenditures: 0
Operating cash flow: 1428479000
Depreciation & amortization: 79445000
Net tangible assets: 4334410000
Owner earnings: 648296000
Return on net tangible assets (%): 14.95696069361228
Buffett classification: The Gruesome
Stock price: 18.37
P/E ratio: 10.704926316381618
Shares outstanding: 331492000
Book value: 6400802000
P/B ratio: 0.9513664131463526
Market cap (USD): 6089508040
Debt to equity: 0.30976383896892923
Effective tax rate (%): 27.132695502691927
COGS to revenue (%): 0
SG&A to revenue (%): 29.5159595950916
Free cash flow (dilution-adjusted): 1399691000
Buyback yield (%): 0.39614037524121576
Retained earnings: 1218445000
Receivables turnover: 9.470473942809477
Capitalized R&D asset: 0
FCF margin (%): 75.17331273845942
Rule of 40 score: 75.17331273845942
Financial ratios for VLYPO — annual report dated 2023-12-31
Total revenue: 1879927000
Net income: 498511000
Capital expenditures: 0
Operating cash flow: 378192000
Depreciation & amortization: 83205000
Net tangible assets: 4672124000
Owner earnings: 581716000
Return on net tangible assets (%): 12.450782556284894
Buffett classification: The Gruesome
Stock price: 18.87
P/E ratio: 12.547875653696709
Shares outstanding: 331492000
Book value: 6701391000
P/B ratio: 0.933426215542415
Market cap (USD): 6255254040
Debt to equity: 0.5430609853984046
Effective tax rate (%): 26.509290435951716
COGS to revenue (%): 0
SG&A to revenue (%): 31.462870632742657
Free cash flow (dilution-adjusted): 345090000
Buyback yield (%): 0.18344578695959726
Retained earnings: 1471371000
Receivables turnover: 7.657606171944375
Capitalized R&D asset: 0
FCF margin (%): 18.35656384529825
Revenue growth (%): 0.9653847145361428
Rule of 40 score: 19.321948559834393
Financial ratios for VLYPO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 21.64
Shares outstanding: 331492000
Market cap (USD): 7173486880
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VLYPO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.25
Shares outstanding: 331492000
Market cap (USD): 7375697000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VLYPO — annual report dated 2024-12-31
Total revenue: 1842804000
Net income: 380271000
Capital expenditures: 0
Operating cash flow: 548540000
Depreciation & amortization: 78834000
Net tangible assets: 5437530000
Owner earnings: 459105000
Return on net tangible assets (%): 8.443263761303387
Buffett classification: The Gruesome
Stock price: 22.25
P/E ratio: 19.39589661057509
Shares outstanding: 331492000
Book value: 7435127000
P/B ratio: 0.9920068614833344
Market cap (USD): 7375697000
Debt to equity: 0.4868663305952945
Effective tax rate (%): 13.28289082115028
COGS to revenue (%): 0
SG&A to revenue (%): 33.06238753551653
Free cash flow (dilution-adjusted): 519552000
Buyback yield (%): 0.12021914674640241
Retained earnings: 1598048000
Receivables turnover: 7.68023805852272
Capitalized R&D asset: 0
FCF margin (%): 28.19355720955674
Revenue growth (%): -1.974704336923721
Rule of 40 score: 26.21885287263302
Financial ratios for VLYPO — quarterly report dated 2025-03-31
Total revenue: 478413000
Net income: 106058000
Capital expenditures: 0
Operating cash flow: -17122000
Depreciation & amortization: 17911000
Net tangible assets: 5509621000
Owner earnings: 123969000
Return on net tangible assets (%): 2.2500458742987948
Buffett classification: The Gruesome
Stock price: 21.86
P/E ratio: 17.081255350845765
Shares outstanding: 331492000
Book value: 7499897000
P/B ratio: 0.9662019518401386
Market cap (USD): 7246415120
Debt to equity: 0.4475318794378109
Effective tax rate (%): 23.76509488211616
COGS to revenue (%): 0
SG&A to revenue (%): 32.50016199392575
Free cash flow (dilution-adjusted): -23962000
Buyback yield (%): 0.12694552889484478
Retained earnings: 1634690000
Receivables turnover: 2.007389038543843
Capitalized R&D asset: 0
FCF margin (%): -5.008643159780357
Rule of 40 score: -5.008643159780357
Financial ratios for VLYPO — quarterly report dated 2025-06-30
Total revenue: 495008000
Net income: 133167000
Capital expenditures: 0
Operating cash flow: 159154000
Depreciation & amortization: 17457000
Net tangible assets: 5591906000
Owner earnings: 150624000
Return on net tangible assets (%): 2.6936075105697412
Buffett classification: The Gruesome
Stock price: 22.58
P/E ratio: 31.288909436722747
Shares outstanding: 331492000
Book value: 7575421000
P/B ratio: 0.9880756937469217
Market cap (USD): 7485089359.999999
Debt to equity: 0.4558628490746587
Effective tax rate (%): 23.065324020313014
COGS to revenue (%): 0
SG&A to revenue (%): 31.84069752408042
Free cash flow (dilution-adjusted): 152343000
Buyback yield (%): 0.04999272313296739
Retained earnings: 1694903000
Receivables turnover: 2.0774389578559496
Capitalized R&D asset: 0
FCF margin (%): 30.775866248626283
Revenue growth (%): 3.468760255260622
Rule of 40 score: 34.244626503886906
Financial ratios for VLYPO — quarterly report dated 2025-09-30
Total revenue: 511111000
Net income: 163355000
Capital expenditures: 0
Operating cash flow: 5159000
Depreciation & amortization: 16353000
Net tangible assets: 5718780000
Owner earnings: 179708000
Return on net tangible assets (%): 3.1424184878592984
Buffett classification: The Gruesome
Stock price: 23.79
P/E ratio: 19.589136767847386
Shares outstanding: 331492000
Book value: 7695374000
P/B ratio: 1.0247968038980302
Market cap (USD): 7886194680
Debt to equity: 0.4342177521196501
Effective tax rate (%): 22.195232311685835
COGS to revenue (%): 0
SG&A to revenue (%): 30.35348485945323
Free cash flow (dilution-adjusted): 795000
Buyback yield (%): 0.16168761382898045
Retained earnings: 1787141000
Receivables turnover: 2.104541280814952
Capitalized R&D asset: 0
FCF margin (%): 0.15554351207467654
Revenue growth (%): 3.253078738121404
Rule of 40 score: 3.4086222501960806
Financial ratios for VLYPO — annual report dated 2025-12-31
Total revenue: 2025683000
Net income: 597983000
Capital expenditures: 0
Operating cash flow: 343832000
Depreciation & amortization: 68718000
Net tangible assets: 5837887000
Owner earnings: 666701000
Return on net tangible assets (%): 11.420245030436526
Buffett classification: The Gruesome
Stock price: 24.47
P/E ratio: 13.564949572145027
Shares outstanding: 331492000
Book value: 7807698000
P/B ratio: 1.038924563936771
Market cap (USD): 8111609240
Debt to equity: 0.42763308724287236
Effective tax rate (%): 19.611894551467326
COGS to revenue (%): 0
SG&A to revenue (%): 30.744395840810235
Free cash flow (dilution-adjusted): 316553000
Buyback yield (%): 0.8975037855743653
Retained earnings: 1912933000
Receivables turnover: 8.305485512326925
Capitalized R&D asset: 0
FCF margin (%): 15.626976185316261
Revenue growth (%): 9.923952845771987
Rule of 40 score: 25.55092903108825
Financial ratios for VLYPO — quarterly report dated 2025-12-31
Total revenue: 541151000
Net income: 195403000
Capital expenditures: 0
Operating cash flow: 196641000
Depreciation & amortization: 16997000
Net tangible assets: 5837887000
Owner earnings: 212400000
Return on net tangible assets (%): 3.6383026941083307
Buffett classification: The Gruesome
Stock price: 24.47
P/E ratio: 13.564949572145027
Shares outstanding: 331492000
Book value: 7807698000
P/B ratio: 1.038924563936771
Market cap (USD): 8111609240
Debt to equity: 0.42763308724287236
Effective tax rate (%): 11.863114783675531
COGS to revenue (%): 0
SG&A to revenue (%): 28.70640542103775
Free cash flow (dilution-adjusted): 187377000
Buyback yield (%): 0.580772552105826
Retained earnings: 1912933000
Receivables turnover: 2.218768578539301
Capitalized R&D asset: 0
FCF margin (%): 34.62564053286421
Revenue growth (%): 5.877392582041866
Rule of 40 score: 40.503033114906074
Financial ratios for ZAL.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 80.8409090909091
Shares outstanding: 258154635
Market cap (USD): 20869455379.43182
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ZAL.DE — annual report dated 2022-12-31
Total revenue: 11005106382.978724
Gross profit: 4314361702.12766
Operating income: 86170212.76595744
Net income: 17872340.425531916
Capital expenditures: 292021276.59574467
Operating cash flow: 489255319.1489362
Depreciation & amortization: 332340425.5319149
Net tangible assets: 1899042553.1914895
Owner earnings: 58191489.361702144
Return on net tangible assets (%): 3.0642541034115744
Capex to operating income (%): 338.88888888888886
Buffett classification: The Gruesome
Stock price: 35.22340425531915
P/E ratio: 508.7797598125
Shares outstanding: 258154635
Book value: 2339574468.085107
P/B ratio: 3.886640580597489
Market cap (USD): 9093085068.989363
Debt to equity: 0.7806020371044015
Current ratio: 1.4409446671575445
Quick ratio: 0.9474760697046551
Effective tax rate (%): 56.70103092783506
Interest coverage ratio: 1.2918660287081338
COGS to revenue (%): 60.79672879127679
SG&A to revenue (%): 12.32406619750986
Free cash flow (dilution-adjusted): 38085106.38297872
Buyback yield (%): 1.593448383271098
Retained earnings: 774255319.1489363
Inventory turnover: 3.4757115225200335
Receivables turnover: 11.330558598028478
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.045867852091331
FCF margin (%): 0.346067589513572
Rule of 40 score: 0.346067589513572
Financial ratios for ZAL.DE — annual report dated 2023-12-31
Total revenue: 11270111111.11111
Gross profit: 4367111111.111111
Operating income: 212111111.1111111
Net income: 92222222.22222222
Capital expenditures: 207777777.77777776
Operating cash flow: 1055000000
Depreciation & amortization: 371111111.1111111
Net tangible assets: 2193222222.2222223
Owner earnings: 255555555.55555555
Return on net tangible assets (%): 11.652059374841684
Capex to operating income (%): 97.95704557359873
Buffett classification: The Gruesome
Stock price: 23.833333333333332
P/E ratio: 66.71586651506023
Shares outstanding: 258154635
Book value: 2636777777.7777767
P/B ratio: 2.3334106951877303
Market cap (USD): 6152685467.5
Debt to equity: 0.7802452488306437
Current ratio: 1.4886702022064038
Quick ratio: 1.0800317631377443
Effective tax rate (%): 45.71615434924787
Interest coverage ratio: 2.230140186915888
COGS to revenue (%): 61.25050526959214
SG&A to revenue (%): 12.257593832260355
Free cash flow (dilution-adjusted): 670333333.3333334
Buyback yield (%): 0
Retained earnings: 901000000
Inventory turnover: 4.311680199875078
Receivables turnover: 17.001508548441166
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.4774369077774665
FCF margin (%): 5.947885754848124
Revenue growth (%): 2.408016051005761
Rule of 40 score: 8.355901805853884
Financial ratios for ZAL.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32.91111111111111
Shares outstanding: 258154635
Market cap (USD): 8496155876.333333
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ZAL.DE — annual report dated 2024-12-31
Total revenue: 11013020833.333334
Gross profit: 4481250000
Operating income: 408229166.6666667
Net income: 261562500
Capital expenditures: 125625000
Operating cash flow: 681354166.6666667
Depreciation & amortization: 364479166.6666667
Net tangible assets: 2357395833.3333335
Owner earnings: 500416666.66666675
Return on net tangible assets (%): 21.227519773761657
Capex to operating income (%): 30.77315641745343
Buffett classification: The Good
Stock price: 33.739583333333336
P/E ratio: 33.29999453464755
Shares outstanding: 258154635
Book value: 2776354166.666666
P/B ratio: 3.13721855988069
Market cap (USD): 8710029820.46875
Debt to equity: 0.6473942895734066
Current ratio: 1.366306608856921
Quick ratio: 0.9779203528733615
Effective tax rate (%): 31.766304347826086
Interest coverage ratio: 4.19593147751606
COGS to revenue (%): 59.30952943958383
SG&A to revenue (%): 14.116812485221091
Free cash flow (dilution-adjusted): 380104166.6666666
Buyback yield (%): 1.1899595692515712
Retained earnings: 1106250000
Inventory turnover: 4.046267019423114
Receivables turnover: 17.801818487960936
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.812709700035056
FCF margin (%): 3.451406951998108
Revenue growth (%): -2.28116897201052
Rule of 40 score: 1.1702379799875877
Financial ratios for ZAL.DE — quarterly report dated 2024-12-31
Total revenue: 3436979166.666667
Gross profit: 1431562500
Operating income: 173750000
Net income: 125000000
Capital expenditures: 48229166.66666667
Operating cash flow: 381562500
Depreciation & amortization: 109583333.33333334
Net tangible assets: 2357395833.3333335
Owner earnings: 186354166.6666667
Return on net tangible assets (%): 7.905085944059034
Capex to operating income (%): 27.757793764988016
Buffett classification: The Good
Stock price: 33.739583333333336
P/E ratio: 17.420059640937502
Shares outstanding: 258154635
Book value: 2776354166.666666
P/B ratio: 3.13721855988069
Market cap (USD): 8710029820.46875
Debt to equity: 0.6473942895734066
Current ratio: 1.366306608856921
Quick ratio: 0.9779203528733615
Effective tax rate (%): 31.62393162393162
Interest coverage ratio: 7.220779220779221
COGS to revenue (%): 58.348234580997115
SG&A to revenue (%): 14.847704197605696
Free cash flow (dilution-adjusted): 291145833.3333333
Buyback yield (%): 0
Retained earnings: 1106250000
Inventory turnover: 1.242304962250758
Receivables turnover: 5.555649099174945
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.176473533977665
FCF margin (%): 8.470980451583571
Rule of 40 score: 8.470980451583571
Financial ratios for ZAL.DE — quarterly report dated 2025-03-31
Total revenue: 2629891304.347826
Gross profit: 1028478260.8695651
Operating income: 23369565.217391305
Net income: 10760869.56521739
Capital expenditures: 9782608.695652174
Operating cash flow: -155434782.60869566
Depreciation & amortization: 94673913.04347825
Net tangible assets: 2485652173.9130435
Owner earnings: 95652173.91304347
Return on net tangible assets (%): 3.8481721182438338
Capex to operating income (%): 41.860465116279066
Buffett classification: The Good
Stock price: 34.52173913043478
P/E ratio: 207.04523251515153
Shares outstanding: 258154635
Book value: 2923804347.826088
P/B ratio: 3.048065432767016
Market cap (USD): 8911946964.782608
Debt to equity: 0.6369381761403767
Current ratio: 1.358226711015077
Quick ratio: 0.8943892786909127
Effective tax rate (%): 44.692737430167604
Interest coverage ratio: 1.1813186813186813
COGS to revenue (%): 60.89274643521389
SG&A to revenue (%): 13.866501343252738
Free cash flow (dilution-adjusted): -214347826.0869565
Buyback yield (%): 0
Retained earnings: 1165108695.6521738
Inventory turnover: 0.7711593823606386
Receivables turnover: 2.592136275980287
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5389686896793762
FCF margin (%): -8.150444306674933
Revenue growth (%): -23.482477582242378
Rule of 40 score: -31.63292188891731
Financial ratios for ZAL.DE — quarterly report dated 2025-06-30
Total revenue: 3335411764.7058825
Gross profit: 1361647058.8235295
Operating income: 170823529.4117647
Net income: 113647058.8235294
Capital expenditures: 40235294.11764706
Operating cash flow: 333882352.9411765
Depreciation & amortization: 99294117.64705883
Net tangible assets: 2779882352.9411764
Owner earnings: 172705882.3529412
Return on net tangible assets (%): 6.212704727241949
Capex to operating income (%): 23.553719008264462
Buffett classification: The Great
Stock price: 32.88235294117647
P/E ratio: 34.035533177756015
Shares outstanding: 258154635
Book value: 3283764705.882352
P/B ratio: 2.5850609229901127
Market cap (USD): 8488731821.470589
Debt to equity: 0.603647176841502
Current ratio: 1.3838545382968779
Quick ratio: 0.975764584307261
Effective tax rate (%): 33.608247422680414
Interest coverage ratio: 7.891304347826088
COGS to revenue (%): 59.176043173080316
SG&A to revenue (%): 13.234101089908645
Free cash flow (dilution-adjusted): 239529411.7647059
Buyback yield (%): 0
Retained earnings: 1374705882.3529413
Inventory turnover: 1.0115157361630291
Receivables turnover: 2.823804780876494
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.5725709224220656
FCF margin (%): 7.1814045359952035
Revenue growth (%): 26.826981753643814
Rule of 40 score: 34.00838628963902
Financial ratios for ZAL.DE — quarterly report dated 2025-09-30
Total revenue: 3553647058.8235297
Gross profit: 1406117647.0588236
Operating income: 57764705.88235294
Net income: 17411764.70588235
Capital expenditures: 19058823.529411767
Operating cash flow: 122000000
Depreciation & amortization: 126823529.41176471
Net tangible assets: 1444470588.235294
Owner earnings: 125176470.58823529
Return on net tangible assets (%): 8.665906499429875
Capex to operating income (%): 32.9938900203666
Buffett classification: The Good
Stock price: 30.6
P/E ratio: 29.606254843409875
Shares outstanding: 258154635
Book value: 3373764705.882354
P/B ratio: 2.341459028611779
Market cap (USD): 7899531831
Debt to equity: 0.5021794469435436
Current ratio: 1.1216554297587245
Quick ratio: 0.5867574099987278
Effective tax rate (%): 66.66666666666666
Interest coverage ratio: 2.7277777777777774
COGS to revenue (%): 60.43170231079918
SG&A to revenue (%): 13.613189432563066
Free cash flow (dilution-adjusted): 34000000
Buyback yield (%): 0
Retained earnings: 3058823.529411765
Inventory turnover: 0.7235324428237346
Receivables turnover: 3.076594011000204
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1465265615878577
FCF margin (%): 0.9567635569092233
Revenue growth (%): 6.54297908363021
Rule of 40 score: 7.499742640539433
Financial ratios for ZAL.DE — annual report dated 2025-12-31
Total revenue: 14524941176.470589
Gross profit: 5792705882.3529415
Operating income: 455647058.8235294
Net income: 253058823.52941176
Capital expenditures: 115294117.64705883
Operating cash flow: 1325058823.5294118
Depreciation & amortization: 476352941.1764706
Net tangible assets: 1374588235.2941177
Owner earnings: 614117647.0588235
Return on net tangible assets (%): 44.676480657309135
Capex to operating income (%): 25.303382390911437
Buffett classification: The Good
Stock price: 29.811764705882354
P/E ratio: 30.412080199442123
Shares outstanding: 258154635
Book value: 3324470588.2352943
P/B ratio: 2.314968664059735
Market cap (USD): 7696045236.3529415
Debt to equity: 0.510156415882228
Current ratio: 1.1064868025729437
Quick ratio: 0.6820115742141027
Effective tax rate (%): 40.65290178571429
Interest coverage ratio: 5.31275720164609
COGS to revenue (%): 60.118902982294145
SG&A to revenue (%): 13.495650483549596
Free cash flow (dilution-adjusted): 955176470.5882354
Buyback yield (%): 1.5011529716456526
Retained earnings: 1502470588.235294
Inventory turnover: 3.5259132582775163
Receivables turnover: 15.03433999025816
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.010329424902288
FCF margin (%): 6.576112488053004
Revenue growth (%): 31.888801413211297
Rule of 40 score: 38.4649139012643
Financial ratios for ZAL.DE — quarterly report dated 2025-12-31
Total revenue: 4789529411.764706
Gross profit: 1911882352.9411764
Operating income: 201764705.88235295
Net income: 110235294.11764707
Capital expenditures: 45294117.64705882
Operating cash flow: 1037411764.7058824
Depreciation & amortization: 147764705.88235295
Net tangible assets: 1374588235.2941177
Owner earnings: 212705882.3529412
Return on net tangible assets (%): 15.47415268743581
Capex to operating income (%): 22.448979591836736
Buffett classification: The Great
Stock price: 29.811764705882354
P/E ratio: 30.533199606447262
Shares outstanding: 258154635
Book value: 3324470588.2352943
P/B ratio: 2.314968664059735
Market cap (USD): 7696045236.3529415
Debt to equity: 0.510156415882228
Current ratio: 1.1064868025729437
Quick ratio: 0.6820115742141027
Effective tax rate (%): 40.507936507936506
Interest coverage ratio: 9.371584699453553
COGS to revenue (%): 60.08204170862913
SG&A to revenue (%): 13.369850900248093
Free cash flow (dilution-adjusted): 913764705.882353
Buyback yield (%): 0
Retained earnings: 1502470588.235294
Inventory turnover: 1.1619400503539024
Receivables turnover: 4.95750121773015
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.989856690861716
FCF margin (%): 19.07838176414237
Revenue growth (%): 34.77785870356881
Rule of 40 score: 53.85624046771118
Financial ratios for ZFIN.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 319.60439560439556
Shares outstanding: 149369269
Market cap (USD): 47739074940.61538
Buyback yield (%): 1.047360051743715
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ZFIN.DE — annual report dated 2022-12-31
Total revenue: 48655434782.608696
Net income: 4672826086.956522
Capital expenditures: 522826086.9565217
Operating cash flow: 5480434782.608695
Depreciation & amortization: 821739130.4347826
Net tangible assets: 16063043478.260868
Owner earnings: 4971739130.434783
Return on net tangible assets (%): 30.95141426444716
Buffett classification: The Gruesome
Stock price: 319.60439560439556
P/E ratio: 10.216317502992823
Shares outstanding: 149369269
Book value: 29271739130.434753
P/B ratio: 1.6308930169092533
Market cap (USD): 47739074940.61538
Debt to equity: 0.5835499443000377
Effective tax rate (%): 20.022329735764792
COGS to revenue (%): 0
SG&A to revenue (%): 19.35750508232245
Free cash flow (dilution-adjusted): 4898913043.478261
Buyback yield (%): 1.7531896518318701
Retained earnings: 38383695652.17391
Receivables turnover: 5.135727397888941
Capitalized R&D asset: 0
FCF margin (%): 10.068583428277819
Rule of 40 score: 10.068583428277819
Financial ratios for ZFIN.DE — annual report dated 2023-12-31
Total revenue: 92973809523.80952
Net income: 5615476190.476191
Capital expenditures: 429761904.7619048
Operating cash flow: 8744047619.047619
Depreciation & amortization: 1014285714.2857143
Net tangible assets: 15870238095.238096
Owner earnings: 6200000000
Return on net tangible assets (%): 39.066836696421866
Buffett classification: The Gruesome
Stock price: 319.60439560439556
P/E ratio: 8.501340460062945
Shares outstanding: 149369269
Book value: 31284523809.523804
P/B ratio: 1.5259645705741056
Market cap (USD): 47739074940.61538
Debt to equity: 0.5881121808287988
Effective tax rate (%): 26.958810777330438
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 8246428571.428572
Buyback yield (%): 5.044784249232227
Retained earnings: 39097619047.61905
Receivables turnover: 7.515927244731016
Capitalized R&D asset: 0
FCF margin (%): 8.869625342518376
Revenue growth (%): 91.08617555102376
Rule of 40 score: 99.95580089354213
Financial ratios for ZFIN.DE — annual report dated 2024-12-31
Total revenue: 95606666666.66667
Net income: 6893333333.333333
Capital expenditures: 401111111.1111111
Operating cash flow: 8447777777.777778
Depreciation & amortization: 1012222222.2222222
Net tangible assets: 15598888888.88889
Owner earnings: 7504444444.444445
Return on net tangible assets (%): 48.10883966094451
Buffett classification: The Gruesome
Stock price: 319.60439560439556
P/E ratio: 6.925397718657937
Shares outstanding: 149369269
Book value: 29931111111.111084
P/B ratio: 1.5949650102663107
Market cap (USD): 47739074940.61538
Debt to equity: 0.5356002672804222
Effective tax rate (%): 26.709982279976373
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 8036666666.666666
Buyback yield (%): 3.0466540171833834
Retained earnings: 37581111111.11111
Capitalized R&D asset: 0
FCF margin (%): 8.405968900355623
Revenue growth (%): 2.831826679300371
Rule of 40 score: 11.237795579655995
Financial ratios for ZFIN.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 15598888888.88889
Buffett classification: The Gruesome
Stock price: 319.60439560439556
Shares outstanding: 149369269
Book value: 29931111111.111084
P/B ratio: 1.5949650102663107
Market cap (USD): 47739074940.61538
Debt to equity: 0.5356002672804222
Buyback yield (%): 0
Retained earnings: 37581111111.11111
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ZFIN.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 15361250000
Buffett classification: The Gruesome
Stock price: 664.8470588235294
Shares outstanding: 149369269
Market cap (USD): 99307719173.2706
Buyback yield (%): 0
Retained earnings: 40230000000
Capitalized R&D asset: 0
Rule of 40 score: 0